Vnitr Lek 2011, 57(10):839-846

The role of central nervous system in etiopathogenesis of peripheral organ diseases

B. Mravec1,2
1 Ústav patologickej fyziológie Lekárskej fakulty UK Bratislava, Slovenská republika, prednosta doc. MUDr. Marián Bernadič, CSc., mim. prof.
2 Ústav experimentálnej endokrinológie SAV Bratislava, Slovenská republika, riaditeľ prof. MUDr. Iwar Klimeš, DrSc.

Current research on the etiopathogenesis of diseases of peripheral organs is primarily focused on the study of processes affecting those organs directly altered by diseases. As a result, therapeutic interventions are focused on the cells of those organs affected by pathological processes. However, pathological processes are not restricted to any "circumscribed" group of cells. Cells of tissue affected by pathological process interact with cells in the surrounding tissues. Moreover, pathologic processes also induce changes in the activity of the neuroendocrine and immune systems, which also affect the progression of pathological processes. The neurobiological view of diseases is based on the assumption that the nervous system processes signals related to pathological processes in peripheral organs and then consequently modulates it via the autonomic, neuroendocrine, and neuroimmune regulations. The aim of this paper is to explain the basis of the neurobiological view of diseases of the peripheral organs, and then discuss possible therapeutic consequences.

Keywords: immune system; neuroendocrine system; neurobiology of diseases; inflammation

Received: January 10, 2011; Accepted: April 11, 2011; Published: October 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mravec B. The role of central nervous system in etiopathogenesis of peripheral organ diseases. Vnitr Lek. 2011;57(10):839-846.
Download citation

References

  1. Mravec B. Neurobiológia chorôb periférnych tkanív. Bratislava SAP 2008.
  2. Mravec B, Ondicova K, Valaskova Z et al. Neurobiological principles in the etio-pathogenesis of disease: when diseases have a head. Med Sci Monit 2009; 15: RA6-RA16.
  3. Valášková Z, Kiňová S, Danihel L et al. The complexity of interactions of the tumour growth process. Vnitř Lék 2009; 55: 1145-1158. Go to PubMed...
  4. Lane RD, Waldstein SR, Chesney MA et al. The rebirth of neuroscience in psychosomatic medicine, Part I: historical context, methods, and relevant basic science. Psychosom Med 2009; 71: 117-134. Go to original source... Go to PubMed...
  5. Koukolík F. Mozek a jeho duše. 3. vyd. Praha: Galén; 2005.
  6. Jänig W. The integrative action of the autonomic nervous system. Neurobiology of homeostasis. Cambridge: Cambridge University Press 2006. Go to original source...
  7. Banks WA, Erickson MA. The blood-brain barrier and immune function and dysfunction. Neurobiol Dis 2010; 37: 26-32. Go to original source... Go to PubMed...
  8. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008; 8: 279-289. Go to original source... Go to PubMed...
  9. Hwang IK, Yoo KY, Han TH et al. Enhanced cell proliferation and neuroblast differentiation in the rat hippocampal dentate gyrus following myocardial infarction. Neurosci Lett 2009; 450: 275-280. Go to original source... Go to PubMed...
  10. Felder RB, Francis J, Zhang ZH et al. Heart failure and the brain: new perspectives. Am J Physiol Regul Integr Comp Physiol 2003; 284: R259-276. Go to original source... Go to PubMed...
  11. Li YF, Patel KP. Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: the altered inhibitory mechanisms. Acta Physiol Scand 2003; 177: 17-26. Go to original source... Go to PubMed...
  12. Kergozien S, Delcros JG, Jouan H et al. Induction of Fos protein expression in spinal cord neurons of tumour-bearing rats. Br J Cancer 1999; 80: 1512-1517. Go to original source... Go to PubMed...
  13. Konsman JP, Blomqvist A. Forebrain patterns of c-Fos and FosB induction during cancer-associated anorexia-cachexia in rat. Eur J Neurosci 2005; 21: 2752-2766. Go to original source... Go to PubMed...
  14. Pirnik Z, Bundzikova J, Bizik J et al. Activity of brain stem groups of catecholaminergic cells in tumor-bearing rats: response to immobilization stress. Ann N Y Acad Sci 2008; 1148: 141-147. Go to original source... Go to PubMed...
  15. Hollis JH, Lightman SL, Lowry CA. Integration of systemic and visceral sensory information by medullary catecholaminergic systems during peripheral inflammation. Ann N Y Acad Sci 2004; 1018: 71-75. Go to original source... Go to PubMed...
  16. Tashiro M, Kubota K, Itoh M et al. Hypometabolism in the limbic system of cancer patients observed by positron emission tomography. Psychooncology 1999; 8: 283-286. Go to original source...
  17. Tashiro M, Itoh M, Kubota K et al. Relationship between trait anxiety, brain activity and natural killer cell activity in cancer patients: a preliminary PET study. Psychooncology 2001; 10: 541-546. Go to original source... Go to PubMed...
  18. Golan H, Kennedy JA, Frenkel A et al. Brain Mapping of Patients with Lung Cancer and Controls: Inquiry into Tumor-to-Brain Communication. J Nucl Med 2009; 50: 1072-1075. Go to original source... Go to PubMed...
  19. Peng YP, Qiu YH, Qiu J et al. Cerebellar interposed nucleus lesions suppress lymphocyte function in rats. Brain Res Bull 2006; 71: 10-17. Go to original source... Go to PubMed...
  20. Pirnik Z, Bundzikova J, Francisty T et al. Effect of liver ischemia-reperfusion injury on the activity of neurons in the rat brain. Cell Mol Neurobiol 2009; 29: 951-960. Go to original source... Go to PubMed...
  21. Bundzikova J, Pirnik Z, Lackovicova L et al. Activation of different neuronal phenotypes in the rat brain induced by liver ischemia-reperfusion injury: Dual Fos/neuropeptide immunohistochemistry. Cell Mol Neurobiol 2011; 31: 293-310. Go to original source... Go to PubMed...
  22. Palkovits M, Sebekova K, Gallatz K et al. Neuronal activation in the CNS during different forms of acute renal failure in rats. Neuroscience 2009; 159: 862-882. Go to original source... Go to PubMed...
  23. Heidland A, Sebekova K, Klassen A et al. Mechanisms of acute uremic encephalopathy: early activation of Fos and Fra-2 gene products in different nuclei//areas of the rat brain. J Ren Nutr 2010; 20: S44-S50. Go to original source... Go to PubMed...
  24. Carlson DE, Chiu WC, Fiedler SM et al. Central neural distribution of immunoreactive Fos and CRH in relation to plasma ACTH and corticosterone during sepsis in the rat. Exp Neurol 2007; 205: 485-500. Go to original source... Go to PubMed...
  25. Petrovický P. Anatomie s topografií a klinickými aplikacemi. III. svazek. Neuroanatomie, smyslová ústrojí a kůže. Martin: Vydavateľstvo Osveta 2002.
  26. Mendler L, Pintér S, Kiricsi M et al. Regeneration of reinnervated rat soleus muscle is accompanied by fiber transition toward a faster phenotype. J Histochem Cytochem 2008; 56: 111-123. Go to original source... Go to PubMed...
  27. Gauthier GF, Burke RE, Lowey S et al. Myosin isozymes in normal and cross-reinnervated cat skeletal muscle fibers. J Cell Biol 1983; 97: 756-771. Go to original source... Go to PubMed...
  28. Bartness TJ, Song CK. Brain-adipose tissue neural crosstalk. Physiol Behav 2007; 91: 343-351. Go to original source... Go to PubMed...
  29. Ganong WF. Přehled lékařské fyziologie. 20. vyd. Praha: Galén 2005.
  30. Sternberg EM. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol 2006; 6: 318-328. Go to original source... Go to PubMed...
  31. Tracey KJ. The inflammatory reflex. Nature 2002; 420: 853-859. Go to original source... Go to PubMed...
  32. Andersson J. The inflammatory reflex - introduction. J Intern Med 2005; 257: 122-125. Go to original source... Go to PubMed...
  33. Tracey KJ. Understanding immunity requires more than immunology. Nat Immunol 2010; 11: 561-564. Go to original source... Go to PubMed...
  34. Couzin-Frankel J. Inflammation bares a dark side. Science 2010; 330: 1621. Go to original source... Go to PubMed...
  35. Szczepanska-Sadowska E, Cudnoch-Jedrzejewska A, Ufnal M et al. Brain and cardiovascular diseases: common neurogenic background of cardiovascular, metabolic and inflammatory diseases. J Physiol Pharmacol 2010; 61: 509-521. Go to PubMed...
  36. Mravec B, Ondičová K. Nervus vagus. Bratislava: SAP 2010.
  37. Meisel C, Schwab JM, Prass K et al. Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci 2005; 6: 775-786. Go to original source... Go to PubMed...
  38. Koch HJ, Uyanik G, Bogdahn U et al. Relation between laterality and immune response after acute cerebral ischemia. Neuroimmunomodulation 2006; 13: 8-12. Go to original source... Go to PubMed...
  39. Keyszer G, Langer T, Kornhuber M et al. Neurovascular mechanisms as a possible cause of remission of rheumatoid arthritis in hemiparetic limbs. Ann Rheum Dis 2004; 63: 1349-1351. Go to original source... Go to PubMed...
  40. Sethi S, Sequeira W. Sparing effect of hemiplegia on scleroderma. Ann Rheum Dis 1990; 49: 999-1000. Go to original source... Go to PubMed...
  41. Dolan AL. Asymmetric rheumatoid vasculitis in a hemiplegic patient. Ann Rheum Dis 1995; 54: 532. Go to original source... Go to PubMed...
  42. Thompson M, Bywaters EG. Unilateral rheumatoid arthritis following hemiplegia. Ann Rheum Dis 1962; 21: 370-377. Go to original source... Go to PubMed...
  43. Yaghmai I, Rooholamini SM, Faunce HF. Unilateral rheumatoid arthritis: protective effect of neurologic deficits. AJR Am J Roentgenol 1977; 128: 299-301. Go to original source... Go to PubMed...
  44. Arruda AP, Milanski M, Velloso LA. Hypothalamic inflammation and thermogenesis: the brown adipose tissue connection. J Bioenerg Biomembr 2011; 43: 53-58. Go to original source... Go to PubMed...
  45. Paton JF, Waki H. Is neurogenic hypertension related to vascular inflammation of the brainstem? Neurosci Biobehav Rev 2009; 33: 89-94. Go to original source... Go to PubMed...
  46. Schwartz PJ. Vagal stimulation for heart failure. Curr Opin Cardiol 2011; 26: 51-54. Go to original source... Go to PubMed...
  47. Schwartz PJ, De Ferrari GM. Vagal stimulation for heart failure: background and first in-man study. Heart Rhythm 2009; 6: S76-S81. Go to original source... Go to PubMed...
  48. Schwartz PJ, De Ferrari GM, Sanzo A et al. Long term vagal stimulation in patients with advanced heart failure: first experience in man. Eur J Heart Fail 2008; 10:884-891. Go to original source... Go to PubMed...
  49. Schwartz PJ. Vagal stimulation for heart diseases: from animals to men. - An example of translational cardiology. Circ J 2010; 75: 20-27. Go to original source... Go to PubMed...
  50. Wyss JM, Carlson SH. The role of the nervous system in hypertension. Curr Hypertens Rep 2001; 3: 255-262. Go to original source... Go to PubMed...
  51. Schlaich MP, Sobotka PA, Krum H et al. Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept. Hypertension 2009; 54: 1195-1201. Go to original source... Go to PubMed...
  52. Krack P, Hariz MI, Baunez C et al. Deep brain stimulation: from neurology to psychiatry? Trends Neurosci 2010; 33: 474-484. Go to original source... Go to PubMed...
  53. Sani S, Jobe K, Smith A et al. Deep brain stimulation for treatment of obesity in rats. J Neurosurg 2007; 107: 809-813. Go to original source... Go to PubMed...
  54. Pisapia JM, Halpern CH, Williams NN et al. Deep brain stimulation compared with bariatric surgery for the treatment of morbid obesity: a decision analysis study. Neurosurg Focus 2010; 29: E15. Go to original source... Go to PubMed...
  55. Gourine A, Bondar SI, Spyer KM et al. Beneficial effect of the central nervous system beta-adrenoceptor blockade on the failing heart. Circ Res 2008; 102: 633-636. Go to original source... Go to PubMed...
  56. Felder RB, Yu Y, Zhang ZH et al. Pharmacological treatment for heart failure: a view from the brain. Clin Pharmacol Ther 2009; 86: 216-220. Go to original source... Go to PubMed...
  57. Li M, Zheng C, Sato T et al. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 2004; 109: 120-124. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.